EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board

"We are delighted with the caliber of scientists and practitioners who have decided to join our SAB said Amir Shiner, CEO of EnzySurge. "They are not only key opinion leaders in the various areas relevant to our field, but they also all bring industry experience, which will be instrumental as we move toward commercializing our products. The individual and collective expertise of our Scientific Advisory Board in diabetic foot, venous and pressure ulcers, biotechnology, clinical development and wound care standards of care, will no doubt accelerate our research and development and will ensure we address the most vital needs of our target market."

EnzySurge's DermaStream(TM) product line is based on its proprietary Continuous Streaming Therapy (CST(TM)) technology. The comprehensive system continuously streams a fresh supply of active solutions to a controlled wound environment. EnzySurge has developed a series of bio-active therapeutic solutions to facilitate safe and effective healing of chronic wounds, from debridement, through regeneration to closure. The DermaStream family of products is designed to treat all forms of chronic wounds including diabetic ulcers, venous ulcers and pressure ulcers. DermaStream touch-free treatments result in faster, more effective and painless wound healing in the hospital, clinics, nursing homes and at home.

The members of EnzySurge's Scientific Advisory Board include:

Chairman, David G. Armstrong DPM, MD, PhD is Professor of Surgery and Associate Dean at the Scholl College of Podiatric Medicine at Rosalind Franklin University of Medicine and Science inChicago. Armstrong is Director of the Center for Lower Extremity Ambulatory Research (CLEAR). He has produced more than 230 peer-reviewed research papers in more than two dozen scholarly medical journals as well as over two dozen book chapters and is co-Editor of the American Diabetes Association (ADA)'s Clinical Care of the Diabetic Foot. Armstrong was selected as one of the first six International Wound Care Ambassadors and is the recipient of numerous awards by national and international medical organizations. He is past Chair of Scientific Sessions for the ADA's Foot Care Council, and a past member of the National Board of Directors of the ADA. Armstrong is the founder and co-chair of the International Diabetic Foot Conference (DF-Con), the largest annual international symposium on the diabetic foot in the world.

Rob Kirsner MD, PhD is a Professor and Vice Chairman of the School of Medicine, University of Miami, School of Dermatology and Cutaneous Surgery. Dr. Kirsner received certifications from the National Board of Medical Examiners, American Board of Dermatology and American Academy of Wound Management. Dr. Kirsner's clinical interests are in wound healing, leg ulcers, skin cancer, medical dermatology and cutaneous surgery. He is active in research in wound healing, health care policy, dermatoepidemiology, inpatient dermatology and cancer control and prevention.

Diane L. Krasner, PhD, RN, FAAN is a Wound & Skin Care Consultant based inYork,Pennsylvania. She works part-time as the WOCN / Special Projects Nurse at Rest Haven -York. She has been the lead co-editor of Chronic Wound Care: A Clinical Source Book for Healthcare Professionals since the first edition was published in 1991. Dr. Krasner is on the editorial boards of Wounds, The International Journal of Wound Care and World Wide Wounds. Dr. Krasner is a Board Certified Legal Nurse Consultant and she serves as an expert witness in legal cases involving wound and skin care.

Joseph L. Mills, MD, PhD serves as Chief of the Division of Vascular Surgery, Professor of Surgery, and Director of the Vascular Surgery Training Program at the University of Arizona Health Sciences Center,Tucson, Arizona. Dr. Mills is certified by the American Board of Surgery with Special Qualifications in Vascular Surgery. His areas of active research interest include open and endovascular treatment of aortic aneurysms, noninvasive evaluation of peripheral vascular disease, hemodialysis access, treatment of carotid and vertebral artery disease to prevent stroke, diabetic foot problems, limb salvage using endovascular techniques and leg bypass surgery, and treatment and prevention of graft stenosis. Dr. Mills has published over 130 manuscripts, produced five films of complex operative techniques, and edited three major textbooks.

Itzhak (Tzaki) Siev-Ner, MD is the Chairman of the Israeli Diabetic Foot Society. Siev-Ner serves as the Director of the Orthopedic Rehabilitation department in the Sheba Medical Center, Tel-Hashomer,Israel. He is Board certified both in Orthopedic Surgery and Physical and Rehabilitation Medicine. His main practice is prevention and treatment (conservative and surgical) of Diabetic Foot Ulcers, chronic wounds, amputations and the rehabilitation of these conditions. He is involved in research of different aspects of wound healing.

About EnzySurge

EnzySurge Ltd. is a developer and provider of innovative solutions for the treatment and management of chronic wounds. EnzySurge's flagship DermaStream(TM) platform based on the proprietary Continuous Streaming Therapy (CST(TM)) offers a new and unique wound treatment modality by continuously streaming a fresh supply of advanced bio-active therapeutic solutions to a controlled wound environment. DermaStream(TM) is designed to deliver effective, affordable and easy-to-use wound treatment throughout all phases of chronic wound treatment cycle from debridement, through regeneration to wound closure. DermaStream(TM) was designed for use in hospitals, clinics, nursing homes and for home care.

EnzySurge is committed to the development and delivery of innovative solutions that improve the quality of life of chronic-wound patients by shortening healing time, preventing hospitalization and reducing treatment costs. visit www.dermastream.com

    PR Contacts:

    Boaz Gruener, Director of Marketing and Business Development
    boazg@dermastream.com
    +972-54-4563608

SOURCE EnzySurge Ltd

Copyright © 2009, PRNewswire
Copyright © 2009, NewsBlaze, Daily News

Tags: ,BIO,HEA,MTC,PDT,FDA,EnzySurge-Ltd